Solventum Corp 10-Q

Item 4. Controls and Procedures Evaluation of Disclosure Controls and Processes The Company carried out an evaluation, under the supervision and with the participation of its management, including the Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of the Company’s “disclosure controls and procedures” (as defined in the Exchange Act Rule 13a-15(e)) as of the end of the period covered by this report. Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures are effective. Changes in Internal Controls Over Financial Reporting During the quarter ended June 30, 2025, we completed the initial phase of a new SAP enterprise resource planning system implementation, which we expect will enhance our transactional processing and financial reporting. The implementation included changes to certain financial processes impacting key controls related to our internal controls over financial reporting. We believe we have maintained appropriate internal control over financial reporting during the implementation and will continue to monitor the impact of the implementation on our processes, procedures and internal control over financial reporting. There have been no other changes in the Company’s internal control over financial reporting (as such term is defined in Rule 13a-15(f) of the Exchange Act) that occurred during the period covered by this report that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting. 38 Table of Contents SOLVENTUM CORPORATION FORM 10-Q For the Quarterly Period Ended September 30, 2025 PART II. Other Information Item 1. Legal Proceedings Discussion of legal matters is incorporated by reference from Part I, Item 1, Note 12, “ Commitments and Contingencies, ” of this document, and should be considered an integral part of Part II, Item 1, “ Legal Proceedings. ” Item 1A. Risk Factors There have been no material changes to the risk factors as disclosed in our 2024 Annual Report on Form 10-K. Discussion of these factors is incorporated by reference into and considered an integral part of Part I, Item 2, “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Item 2. Unregistered Sales of Equity Securities and Use of Proceeds There were no unregistered sales of equity securities during the period covered by this report. Item 3. Defaults Upon Senior Securities No matters require disclosure. Item 4. Mine Safety Disclosures Not applicable.